Bharat Biotech submitted 90 per cent documents to WHO for emergency use listing for Covaxin: Sources

The Hyderabad-based Bharat Biotech Ltd is confident about obtaining WHO's emergency use listing.
Hyderabad-based Bharat Biotech has submitted 90 per cent of documents to World Health Organisation (WHO) for obtaining emergency use listing for the Covaxin, according to sources.
The remaining documents are expected to be submitted by June, the company told the Central government during a discussion on obtaining the WHO's authorisation for emergency use listing for Covaxin, sources said.
The company is confident about obtaining WHO's emergency use listing.
Sources also said that Covaxin received regulatory approval in 11 countries and interest from 11 companies in seven countries for technology transfer and production.

Related Keywords

United States , India , Bharat , , Drug Administration , World Health Organisation , Hyderabad Based Bharat Biotech , Corona Cases , India Corona Cases , Corona India , Orona Cases In India , Corona In India , Today Corona Cases , Total Corona Cases , World Corona Cases , Corona Cases In World , India Total Corona Cases , Total Corona Cases In India , Coronavirus Pandemic , Ovid 19 Pandemic , Ocornavirus , Covid 19 , Coronavirus Vaccine , Coronavirus Vaccine Updates , Corona Vaccine Updates , Coronavirus Vaccine Bharat Biotech , Bharat Biotech , India Coronavirus Vaccine , Russia Coronavirus Vaccine , Coronavirus Vaccine News , Coronavirus Vaccine Latest , Corona Vaccine , Covid Vaccine , ஒன்றுபட்டது மாநிலங்களில் , இந்தியா , பாரத் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , ஹைதராபாத் அடிப்படையிலானது பாரத் பயோடெக் , கொரோனா வழக்குகள் , விட் சர்வதேச பரவல் , விட் ,